TABLE 1.
Spirochete | Mutation positiona | Resistance(s)b | Clinical/inducedc | Referenced |
---|---|---|---|---|
T. pallidum | A2058G | Ery, Azi | Clinical | 71 |
A2059G | Spi | Clinical | 44 | |
T. denticola | A2058G | Ery | Induced | 35 |
B. hyodysenteriae | A2058G | Ery, Cli, Tyl | Induced | 28 |
A2058T | Ery, Cli, Tyl | Clinical | 28 | |
B. pilosicoli | A2058G | Tyl | Induced | 56 |
A2058T | Ery, Cli, Tyl | Clinical | 29 | |
A2059C | Ery, Cli, Tyl | Clinical | 29 | |
A2059G | Ery, Cli, Tyl | Clinical | 29 | |
Brachyspira spp. | A2062C | Tyl | Induced | 56 |
Based on the numbering of the E. coli 23S rRNA gene nucleotide sequence.
Based on the antibiotics tested. Azi, azithromycin; Cli, clindamycin; Ery, erythromycin; Spi, spiramycin; Tyl, tylosin.
Macrolide resistance present in clinical/field isolate versus experimentally induced resistance.
Initial description of mutation.